These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 3122194
1. Progress in immunization against Pseudomonas aeruginosa and Klebsiella spp. Cryz SJ. Pathol Immunopathol Res; 1987; 6(2):147-52. PubMed ID: 3122194 [No Abstract] [Full Text] [Related]
2. Early protection by vaccines in burns. Jones RJ. Br J Exp Pathol; 1971 Feb; 52(1):100-9. PubMed ID: 4993954 [Abstract] [Full Text] [Related]
3. Production and characterization of a human hyperimmune intravenous immunoglobulin against Pseudomonas aeruginosa and Klebsiella species. Cryz SJ, Fürer E, Sadoff JC, Fredeking T, Que JU, Cross AS. J Infect Dis; 1991 May; 163(5):1055-61. PubMed ID: 1902245 [Abstract] [Full Text] [Related]
5. Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa. Hegerle N, Choi M, Sinclair J, Amin MN, Ollivault-Shiflett M, Curtis B, Laufer RS, Shridhar S, Brammer J, Toapanta FR, Holder IA, Pasetti MF, Lees A, Tennant SM, Cross AS, Simon R. PLoS One; 2018 Dec; 13(9):e0203143. PubMed ID: 30188914 [Abstract] [Full Text] [Related]
14. Prevention of pseudomonas respiratory infection in a surgical intensive care unit. Polk HC, Borden S, Aldrete JA. Ann Surg; 1973 May; 177(5):607-15. PubMed ID: 4634109 [No Abstract] [Full Text] [Related]
15. Human monoclonal antibodies to Pseudomonas aeruginosa type-specific lipopolysaccharides, toxin A and Klebsiella capsular polysaccharides. Lang AB, Fürer E, Schürch U, Cross AS, Larrick JW, Cryz SJ. Dev Biol Stand; 1990 May; 71():121-6. PubMed ID: 1698165 [Abstract] [Full Text] [Related]
16. Management of outbreaks of Gram-negative bacteria in neonatal units. Gray J, Hobbs PM. J Hosp Infect; 2002 Dec; 52(4):317-8. PubMed ID: 12473482 [No Abstract] [Full Text] [Related]
18. Vaccine development and passive immunization for Pseudomonas aeruginosa in critically ill patients: a clinical update. Vincent JL. Future Microbiol; 2014 May 21; 9(4):457-63. PubMed ID: 24810345 [Abstract] [Full Text] [Related]
19. Bacteriological and histopathological estimation of Aerodin efficacy administered by respiratory way to mice and guinea pigs experimentally infected. Popescu C, Pencea I, Anton D, Hoisie S, Leibovici AD, Leibovici M, Grigoras E, Thirer O. Arch Roum Pathol Exp Microbiol; 1979 May 21; 38(2):155-66. PubMed ID: 122262 [No Abstract] [Full Text] [Related]